ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $382,000 | -68.1% | 8,919 | -84.5% | 0.04% | -18.2% |
| Q3 2018 | $1,198,000 | +24.8% | 57,727 | -8.2% | 0.04% | +29.4% |
| Q2 2018 | $960,000 | -30.3% | 62,896 | +2.6% | 0.03% | -34.6% |
| Q1 2018 | $1,378,000 | -21.8% | 61,319 | +4.8% | 0.05% | -23.5% |
| Q4 2017 | $1,762,000 | +68.9% | 58,517 | +61.8% | 0.07% | +61.9% |
| Q4 2016 | $1,043,000 | -42.6% | 36,171 | -36.7% | 0.04% | -44.7% |
| Q3 2016 | $1,818,000 | +618.6% | 57,149 | +410.3% | 0.08% | +985.7% |
| Q2 2014 | $253,000 | – | 11,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |